Intracellular innate immune cascades and interferon defenses that control hepatitis C virus
about
Modulation of the type I interferon pathways by culture-adaptive hepatitis C virus core mutantsDominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infectionModulation of host lipid metabolism by hepatitis C virus: Role of new therapiesRegulation of hepatic innate immunity by hepatitis C virusEmerging concepts in immunity to hepatitis C virus infection.Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsGenetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time.Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression.Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.Production of IFN-β during Listeria monocytogenes infection is restricted to monocyte/macrophage lineageCytokine-induced tumor suppressors: a GRIM storyRNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infectionUridine composition of the poly-U/UC tract of HCV RNA defines non-self recognition by RIG-I.IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and diseaseHepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cellsNK cells, innate immunity and hepatitis C infection after liver transplantation.Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?Antiviral interferon-beta signaling induced by designed transcription activator-like effectors (TALE).Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.Hepatitis C Virus. Strategies to Evade Antiviral ResponsesActivation and evasion of antiviral innate immunity by hepatitis C virus.Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage.Hepatitis C virus infection of neuroepithelioma cell lines.The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication SitesHepatitis C Virus Sensing by Human Trophoblasts Induces Innate Immune Responses and Recruitment of Maternal NK Cells: Potential Implications for Limiting Vertical Transmission.Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infectionHepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replicationRelease of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells.Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate Immunity.Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies.Interferon-α in acute myeloid leukemia: an old drug revisited.Host genetics in immune-mediated hepatitis C virus clearance.RIG-I like receptors in antiviral immunity and therapeutic applications.Neurological complications of hepatitis C infection.Innate detection of hepatitis B and C virus and viral inhibition of the response.A systematic review and meta-analysis of HCV clearance.
P2860
Q24329074-93B9392B-E818-4B67-B7EF-A82CF72B8510Q24658465-A255ED2A-4A3F-44E2-A9E8-504F4C8ABFCCQ26782009-7D250192-38B3-42F7-BAD1-2D174B3F6573Q26824743-11B59F1D-88BD-4EF8-84E5-9444F18E81C0Q27002588-737A0A49-2E53-4D6F-A582-57C0D2FD51ECQ27014831-A57CBC1A-A87E-4AAF-A686-C29319D202AFQ30402699-54F68466-6471-4835-A707-395041B90226Q33553433-A0894C83-732B-4E39-95C8-6E010503CEEEQ33734636-F1DAE1DB-3A22-42D4-95C3-F2830F167360Q33873396-9A8C9708-C7B3-4611-90DA-6186C973F600Q34077445-A7CC8415-E891-4A29-B4BB-3BD4D952C848Q34210374-BEA9EB1C-BEB4-4E4D-AB86-C1B84D4EE185Q34282251-98C0FB40-D9FC-48D5-AFFB-1DD96CA3ED7EQ34388463-90768146-917D-499A-961C-9E8EB11C54DDQ34697945-FF2E4111-1A5C-44A8-AE05-9F9F8EBA632DQ34699732-570F3AED-3BE2-42AA-A6C2-1FFC6D62A22EQ35019869-97685E3F-AE7C-456F-8BFB-E43479027FDFQ35154109-4B716BEE-5316-4D0F-A818-14B1A9A8D662Q35270150-E80141DA-7E99-45FC-A779-3F36E2E4CB73Q35484998-BB6C8AD1-1269-4CCE-93CA-2475DC9FEE74Q35526955-856C5A09-24B3-4F0F-AC43-9C786A34E105Q35604054-4818695D-8652-4DAF-8572-B8EA783ECF51Q35606341-BAD4C9E2-A09A-4A65-AF05-89C982AEF523Q35660303-AE4B7218-9D60-4120-AE92-FEB7C2B990ADQ35818245-043C2787-41FB-4767-ADC5-786A3F9D5419Q35919836-87947E97-073B-4726-9261-EE91DBBC8002Q36119372-DC609EAB-F477-4C46-8B25-141B514B0733Q36379299-0153A55B-21BC-4A73-9741-3872B56F49EBQ36612971-37F0587A-1014-45A4-9448-9C7CFDA2A6ACQ36759684-BD0B4EC7-06BB-49DB-854E-07A292726B72Q36911650-C129925E-5ECD-4094-BA91-A8F1A79A6141Q37095314-659C73E0-4E82-4FB0-B4D5-47F4A84CEE37Q37426836-F553202E-55D0-427D-9E9C-A990459ACF09Q37721750-3FD2B5B9-3235-49C9-8CCD-42724DB8C787Q37832939-458B2D7E-7BC5-4D76-8BA3-76A40D710320Q37862746-4C784615-38ED-4C68-BBAE-BC3BE9FC0D65Q37945229-FD37D2DF-5D8E-4C80-AD86-A4ADE7514DB2Q38044680-B6F41F2A-A711-4C44-8ECD-4C793EFBE548Q38560972-8ECD61FE-6935-4B8A-9A3C-66637FEB88BDQ38928083-F5354F2C-B9AF-4240-BB78-2FFB5B55ED35
P2860
Intracellular innate immune cascades and interferon defenses that control hepatitis C virus
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Intracellular innate immune ca ...... that control hepatitis C virus
@ast
Intracellular innate immune ca ...... that control hepatitis C virus
@en
Intracellular innate immune ca ...... that control hepatitis C virus
@nl
type
label
Intracellular innate immune ca ...... that control hepatitis C virus
@ast
Intracellular innate immune ca ...... that control hepatitis C virus
@en
Intracellular innate immune ca ...... that control hepatitis C virus
@nl
prefLabel
Intracellular innate immune ca ...... that control hepatitis C virus
@ast
Intracellular innate immune ca ...... that control hepatitis C virus
@en
Intracellular innate immune ca ...... that control hepatitis C virus
@nl
P2860
P356
P1476
Intracellular innate immune ca ...... that control hepatitis C virus
@en
P2093
Stacy M Horner
P2860
P304
P356
10.1089/JIR.2009.0063
P50
P577
2009-09-01T00:00:00Z